Amended Statement of Changes in Beneficial Ownership (4/a)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Schuyler Kevin	2. Issuer Name and Ticker or Trading Symbol ADIAL PHARMACEUTICALS, INC. [ ADIL ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 1180 SEMINOLE TRAIL, SUITE 495	3. Date of Earliest Transaction (MM/DD/YYYY) 11/12/2018
(Street) CHARLOTTESVILLE, VA 22901 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY) 11/13/2018	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrant to purchase units	$5.00	11/12/2018		J			89600 ⁽¹⁾	7/31/2018	7/31/2023	Units	179200	⁽¹⁾	0	D
Warrant to purchase common stock	$5.00	11/12/2018		J		89600 ⁽¹⁾		11/12/2018	7/31/2023	Common Stock	89600	⁽¹⁾	89600	D
Warrant to purchase common stock	$6.25	11/12/2018		J		89600 ⁽¹⁾		11/12/2018	7/31/2023	Common Stock	89600	⁽¹⁾	89600	D
Warrant to purchase units	$5	11/12/2018		J			192600 ⁽²⁾	7/31/2018	7/31/2023	Units	385200	⁽²⁾	0	I	Owned by MVA 151 Investors LLC
Warrant to purchase common stock	$5.00	11/12/2018		J		192600 ⁽²⁾		11/12/2018	7/31/2023	Common Stock	192600	⁽²⁾	192600	I	Owned by MVA 151 Investors LLC
Warrant to purchase common stock	$6.25	11/12/2018		J		192600 ⁽²⁾		11/12/2018	7/31/2023	Common Stock	192600	⁽²⁾	192600	I	Owned by MVA 151 Investors LLC

Explanation of Responses:
(1)	The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock.
(2)	The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Schuyler Kevin 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE, VA 22901	X	X